Ripple Therapeutics
PrivateLast Round
Grant
Apr 27, 2022
Total Funding Raised
$12.38M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ripple Therapeutics is a clinical-stage ophthalmic therapeutics company developing a drug delivery system for controllable, sustained drug delivery without the use of polymers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ripple Therapeutics Comparables
Compare Ripple Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PolyActiva | 84% | |
| EyePoint, Inc. | 80% | |
| SpyGlass Pharma | 75% | |
Ripple Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 27, 2022 | ||||
| Grant | Feb 5, 2021 | ||||
| Series A | Dec 10, 2020 |
Key People
Founding team and executive leadership
Ripple Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BDC Capital | Series A |
| National Research Council Canada Industrial Research Assistance Program | Grant |
| Natural Sciences and Engineering Research Council of Canada | Grant |
| Théa Open Innovation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 39% MoM.
- Jun 23, 2026
Monthly visitors increased 39% MoM.
Ripple Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ripple Therapeutics's valuation, stock price, and market status.